BLRX: 2024 Financial Results
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
210 Views
BLRX: Aphexda Transition Progressing
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
328 Views
BLRX: Ayrmid Assumes Commercialization Efforts
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
410 Views
BLRX: On Track for 60% Formulary Placement
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
278 Views
BLRX: On Track for 60% Formulary Placement
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
280 Views